Has David Kastenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,824 in general payments to David Kastenberg, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Kastenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Kastenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Kastenberg, MD

Gastroenterology · Phila, PANPI 1205805439

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,879 of the $5,824 with a category attached, or 83.8%. 10 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 34.3% of the total. Reporting peaked in 2021 at $3,934 and has fallen 99.6% since, to $17 in 2025.

$5,824in general payments, 2019–2025

Across 17 payments — averaging $342.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
Medtronic$2K
Covidien LP$1K
Ferring Pharmaceuticals Inc.$499
Fujifilm Healthcare Americas Corporation$182
Shire North American Group Inc$35
plus $69 from 4 others

$31,686in research payments, 2019–2025

Across 10 payments — averaging $3168.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Covidien LP$22K
Takeda Pharmaceuticals U.S.A., Inc.$10K

What the payments were for

Speaking & faculty fees$4,87984%
Travel & lodging$4287%
Food & beverage$5189%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$2,000
Medtronic	2	$1,962
Covidien LP	2	$1,077
Ferring Pharmaceuticals Inc.	3	$499
Fujifilm Healthcare Americas Corporation	2	$182
Shire North American Group Inc	2	$35
Johnson & Johnson	2	$28
Madrigal Pharmaceuticals	1	$17
Pfizer	1	$12
Braintree Laboratories, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XIFAXAN$2,000
CLENPIQ$428
FUJIFILM$143

How this compares

$5,824 in reported general payments places this provider in the 70th percentile of 935 gastroenterology providers in Pennsylvania.

See all gastroenterology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$56,669

Medicare patients

287

Services billed

441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	29	$440,191
LinzessLinaclotide	35	$46,926
Mesalamine	29	$14,743
DexilantDexlansoprazole	28	$13,993
Dexlansoprazole DrDexlansoprazole	33	$12,192
Mesalamine ErMesalamine	12	$2,941
Esomeprazole Magnesium	63	$1,839
CholestyramineCholestyramine (With Sugar)	11	$1,211
Omeprazole	77	$1,138
Famotidine	64	$970
Pantoprazole Sodium	73	$904
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	11	$220
Amitriptyline Hcl	13	$192
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	11	$176

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Phila

David LorenPhila$132K
Mitchell ConnPhila$70K
Thomas KowalskiPhila$57K
Miguel RegueiroPittsburgh$1.5M
Adam PeytonAllentown$985K
Shahin RahimianWaynesboro$592K
Sandra El-HachemPittsburgh$472K
Harshit KharaDanville$438K
Kofi ClarkeHershey$426K
Michael KochmanPhiladelphia$361K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →